Rebecca Hamm
- Molecular Biology
- Pharmacology top 10%
- Cellular and Molecular Neuroscience
- Oncology
- Pharmacology top 10%
- Co-authors
- Thomas EfferthAron H. LichtmanStephen A. VarvelBilly R. MartinAlexander PanossianG. WikmanWen YanYoichi Taya
- Topics
- Bioactive Compounds and Antitumor Agents (2 papers)Cholesterol and Lipid Metabolism (2 papers)Drug Transport and Resistance Mechanisms (2 papers)
- Cited by
- PharmacologyToxicology
- Partner nations
- GermanyUnited StatesSweden
In The Last Decade
Rebecca Hamm
10 papers receiving 450 citations
Peers
Comparison fields: 5 of 74
- Molecular Biology 247
- Pharmacology 146
- Cellular and Molecular Neuroscience 121
- Oncology 81
- Pharmacology 64
Countries citing papers authored by Rebecca Hamm
This map shows the geographic impact of Rebecca Hamm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rebecca Hamm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rebecca Hamm more than expected).
Fields of papers citing papers by Rebecca Hamm
This network shows the impact of papers produced by Rebecca Hamm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rebecca Hamm. The network helps show where Rebecca Hamm may publish in the future.
Co-authorship network of co-authors of Rebecca Hamm
This figure shows the co-authorship network connecting the top 25 collaborators of Rebecca Hamm. A scholar is included among the top collaborators of Rebecca Hamm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rebecca Hamm. Rebecca Hamm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 34 | |
| 2 | 63 | |
| 3 | 23 | |
| 4 | 9 | |
| 5 | 19 | |
| 6 | 57 | |
| 7 | 27 | |
| 8 | 133 | |
| 9 | 25 | |
| 10 | 75 |
About Rebecca Hamm
Rebecca Hamm is a scholar working on Toxicology, Oncology and Endocrine and Autonomic Systems, having authored 10 papers that have together received 465 indexed citations. Recurring topics across this work include Bioactive Compounds and Antitumor Agents (2 papers), Cholesterol and Lipid Metabolism (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). The work is most often cited by research in Pharmacology (146 citations), Pharmacology (64 citations) and Toxicology (25 citations). Rebecca Hamm has collaborated with scholars based in Germany, United States and Sweden. Frequent co-authors include Thomas Efferth, Aron H. Lichtman, Stephen A. Varvel, Billy R. Martin, Alexander Panossian, G. Wikman, Wen Yan, Yoichi Taya, Mini Kapoor and Guillermina Lozano. Their work appears in journals such as Oncogene, Journal of Investigative Dermatology and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.